Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$1.41 - $2.5 $448 - $795
318 Added 2.3%
14,132 $0
Q3 2022

Oct 24, 2022

BUY
$1.66 - $2.79 $3,233 - $5,434
1,948 Added 16.42%
13,814 $24,000
Q2 2022

Aug 02, 2022

BUY
$1.44 - $3.98 $17,087 - $47,226
11,866 New
11,866 $21,000
Q3 2021

Nov 05, 2021

SELL
$7.16 - $9.69 $81,051 - $109,690
-11,320 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$6.23 - $10.03 $70,523 - $113,539
11,320 New
11,320 $105,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $496M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.